Position in CDXS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$92,308
-$106,600 QoQ
Shares Held
56,631
-53.6% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,278,082,994 across 390 Biotechnology names. CDXS ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,308 | 56,631 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $198,908 | 122,030 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $186,862 | 76,583 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $107,830 | 44,193 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $129,823 | 48,262 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $225,196 | 47,211 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $98,276 | 31,908 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $95,365 | 30,763 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $88,547 | 25,372 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $71,000 | 23,279 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $34,669 | 18,344 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $469,108 | 167,539 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $62,766 | 15,161 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,245 | 6,276 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,821 | 2,446 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $127,662 | 12,205 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,409,218 | 359,322 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,068,046 | 353,951 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,740,972 | 2,138,477 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,996,421 | 2,029,851 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $45,427,698 | 1,984,609 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $50,626,192 | 2,319,111 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $28,283,396 | 2,409,148 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $27,857,085 | 2,443,604 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $22,980,559 | 2,059,190 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||